Charles Rhyee
Stock Analyst at TD Cowen
(0.81)
# 3,670
Out of 4,784 analysts
50
Total ratings
30.3%
Success rate
-13.42%
Average return
Main Sectors:
Stocks Rated by Charles Rhyee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CAH Cardinal Health | Upgrades: Buy | $130 → $144 | $136.44 | +5.54% | 2 | Jan 8, 2025 | |
| CRL Charles River Laboratories International | Maintains: Hold | $203 → $227 | $155.55 | +45.93% | 5 | Nov 11, 2024 | |
| FTRE Fortrea Holdings | Maintains: Hold | $23 → $25 | $8.03 | +211.33% | 3 | Nov 11, 2024 | |
| TDOC Teladoc Health | Maintains: Hold | $9 → $8 | $8.09 | -1.11% | 6 | Oct 31, 2024 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $369 → $285 | $179.07 | +59.16% | 3 | Oct 25, 2024 | |
| MEDP Medpace Holdings | Maintains: Buy | $413 → $372 | $312.36 | +19.09% | 3 | Oct 23, 2024 | |
| VEEV Veeva Systems | Maintains: Hold | $180 → $192 | $234.21 | -18.02% | 3 | Aug 29, 2024 | |
| GDRX GoodRx Holdings | Maintains: Buy | $14 → $16 | $4.50 | +255.56% | 7 | May 16, 2024 | |
| TALK Talkspace | Maintains: Outperform | $4 → $5 | $2.63 | +90.11% | 2 | May 3, 2023 | |
| AMWL American Well | Downgrades: Market Perform | $100 → $50 | $7.82 | +539.39% | 3 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $251 | $177.39 | +41.50% | 1 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $56 | $3.58 | +1,464.25% | 2 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $18 → $14 | $0.62 | +2,147.19% | 3 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $48 → $50 | $9.60 | +420.83% | 2 | Jun 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $325 → $361 | $668.06 | -45.96% | 3 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $3,240 | $1.48 | +218,818.92% | 1 | Jul 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $35 | $19.14 | +82.86% | 1 | Feb 13, 2018 |
Cardinal Health
Jan 8, 2025
Upgrades: Buy
Price Target: $130 → $144
Current: $136.44
Upside: +5.54%
Charles River Laboratories International
Nov 11, 2024
Maintains: Hold
Price Target: $203 → $227
Current: $155.55
Upside: +45.93%
Fortrea Holdings
Nov 11, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $8.03
Upside: +211.33%
Teladoc Health
Oct 31, 2024
Maintains: Hold
Price Target: $9 → $8
Current: $8.09
Upside: -1.11%
ICON Public Limited Company
Oct 25, 2024
Maintains: Buy
Price Target: $369 → $285
Current: $179.07
Upside: +59.16%
Medpace Holdings
Oct 23, 2024
Maintains: Buy
Price Target: $413 → $372
Current: $312.36
Upside: +19.09%
Veeva Systems
Aug 29, 2024
Maintains: Hold
Price Target: $180 → $192
Current: $234.21
Upside: -18.02%
GoodRx Holdings
May 16, 2024
Maintains: Buy
Price Target: $14 → $16
Current: $4.50
Upside: +255.56%
Talkspace
May 3, 2023
Maintains: Outperform
Price Target: $4 → $5
Current: $2.63
Upside: +90.11%
American Well
Mar 23, 2023
Downgrades: Market Perform
Price Target: $100 → $50
Current: $7.82
Upside: +539.39%
Dec 6, 2022
Initiates: Outperform
Price Target: $251
Current: $177.39
Upside: +41.50%
Oct 20, 2022
Maintains: Outperform
Price Target: $70 → $56
Current: $3.58
Upside: +1,464.25%
Aug 16, 2022
Maintains: Outperform
Price Target: $18 → $14
Current: $0.62
Upside: +2,147.19%
Jun 21, 2022
Maintains: Outperform
Price Target: $48 → $50
Current: $9.60
Upside: +420.83%
Apr 18, 2022
Maintains: Outperform
Price Target: $325 → $361
Current: $668.06
Upside: -45.96%
Jul 16, 2020
Initiates: Outperform
Price Target: $3,240
Current: $1.48
Upside: +218,818.92%
Feb 13, 2018
Initiates: Market Perform
Price Target: $35
Current: $19.14
Upside: +82.86%